Schroder Investment Management Group Has $6.09 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Schroder Investment Management Group trimmed its position in CVS Health Co. (NYSE:CVS - Free Report) by 3.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 138,494 shares of the pharmacy operator's stock after selling 4,949 shares during the period. Schroder Investment Management Group's holdings in CVS Health were worth $6,085,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Legacy Investment Solutions LLC bought a new stake in CVS Health during the third quarter valued at approximately $31,000. Ridgewood Investments LLC raised its stake in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after buying an additional 450 shares during the period. Stonebridge Financial Group LLC bought a new position in shares of CVS Health during the 4th quarter valued at approximately $28,000. Hopwood Financial Services Inc. purchased a new stake in CVS Health during the 4th quarter valued at approximately $29,000. Finally, Financial Perspectives Inc lifted its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Piper Sandler upped their target price on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research note on Friday, March 21st. JPMorgan Chase & Co. lifted their target price on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research note on Tuesday, February 18th. StockNews.com raised shares of CVS Health from a "sell" rating to a "hold" rating in a research report on Thursday, February 13th. Cantor Fitzgerald upgraded shares of CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Finally, Evercore ISI lifted their price objective on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research note on Monday, January 27th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, CVS Health currently has a consensus rating of "Moderate Buy" and an average target price of $70.39.

Remove Ads

CVS Health Price Performance

CVS traded down $3.97 on Friday, hitting $63.54. 13,291,234 shares of the company were exchanged, compared to its average volume of 11,586,970. The business's fifty day moving average is $63.47 and its 200 day moving average is $58.01. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $74.85. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm has a market capitalization of $80.11 billion, a P/E ratio of 17.36, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, sell-side analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.19%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 72.68%.

Insiders Place Their Bets

In other news, Director Michael F. Mahoney bought 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. 0.24% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.